世界栄養補助食品市場規模シェア、競争環境、トレンド分析レポート:タイプ別(栄養補助食品、機能性飲料、機能性食品)、形態別(カプセル、液体およびグミ、錠剤およびソフトジェル、粉末、その他)、販売チャネル別(オフライン、オンライン):  2024年から2032年までの機会分析および業界予測

レポートID : ROJP0824238  |  発行日 : 2024年08月  |  フォーマット :  :   : 

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Nutraceuticals Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Nutraceuticals Market

5.1. Covid-19: Nutraceuticals Industry Impact
5.2. Nutraceuticals Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Nutraceuticals Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Nutraceuticals Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Nutraceuticals Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increased adoption of fortified food owing to the growing health consciousness amongst consumers
6.1.1.2. Increasing incidences of chronic diseases
6.1.1.3. Strict government regulations on food fortification
6.1.2. Market Restraints
6.1.2.1. High cost associated with the fortified products
6.1.3. Market Opportunities
6.1.3.1. Technological advancements

Chapter 7. Global Nutraceuticals Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. NutraceuticalsMarket Revenue by Market Players (2017 - 2020)
7.1.1.2. Nutraceuticals Market Revenue Market Share by Market Players (2017 - 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Process Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Nutraceuticals Market, By Type

8.1. Nutraceuticals Market, by Type, 2023-2032
8.1.1. Dietary Supplements
8.1.1.1. Market Revenue and Forecast (2023-2032)
8.1.1.2. Proteins & Peptides
8.1.1.3. Market Revenue and Forecast (2023-2032)
8.1.1.4. Vitamins & Minerals
8.1.1.5. Market Revenue and Forecast (2023-2032)
8.1.1.6. Herbals (Ayurveda Extracts, Plant Extracts, Algal Extracts, Phytochemicals)
8.1.1.7. Market Revenue and Forecast (2023-2032)
8.1.1.8. Others (Fatty Acids and Fiber).
8.1.1.9. Market Revenue and Forecast (2023-2032)
8.1.2. Functional Beverages
8.1.2.1. Market Revenue and Forecast (2023-2032)
8.1.2.2. Fruit & Vegetable Juices and Drinks
8.1.2.3. Market Revenue and Forecast (2023-2032)
8.1.2.4. Dairy & Dairy Alternative Drinks
8.1.2.5. Market Revenue and Forecast (2023-2032)
8.1.2.6. Noncarbonated Drinks (Bottled Water, Tea, and Coffee)
8.1.2.7. Market Revenue and Forecast (2023-2032)
8.1.2.8. Other (Herbal Tea, Sports Drinks, and Energy Drinks)
8.1.2.9. Market Revenue and Forecast (2023-2032)
8.1.3. Functional Food
8.1.3.1. Market Revenue and Forecast (2023-2032)
8.1.3.2. Probiotics Fortified Food
8.1.3.3. Market Revenue and Forecast (2023-2032)
8.1.3.4. Omega Fatty Acid Fortified Food
8.1.3.5. Market Revenue and Forecast (2023-2032)
8.1.3.6. Branded Ionized Salt
8.1.3.7. Market Revenue and Forecast (2023-2032)
8.1.3.8. Branded Wheat Flour Market
8.1.3.9. Market Revenue and Forecast (2023-2032)
8.1.3.10. Other Functional Food
8.1.3.11. Market Revenue and Forecast (2023-2032)
8.1.4. Personal Care
8.1.4.1. Market Revenue and Forecast (2023-2032)

Chapter 9. Global Nutraceuticals Market, By Form

9.1. Nutraceuticals Market, by Form, 2023-2032
9.1.1. Capsules
9.1.1.1. Market Revenue and Forecast (2023-2032)
9.1.2. Liquid & Gummies
9.1.2.1. Market Revenue and Forecast (2023-2032)
9.1.3. Tablets &Softgels
9.1.3.1. Market Revenue and Forecast (2023-2032)
9.1.4. Powder
9.1.4.1. Market Revenue and Forecast (2023-2032)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2023-2032)

Chapter 10. Global Nutraceuticals Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue Forecast by Type(2023-2032)
10.1.2. Market Revenue Forecast by Form (2023-2032)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2023-2032)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2023-2032)
10.2. Europe
10.2.1. Market Revenue Forecast by Type (2023-2032)
10.2.2. Market Revenue Forecast by Form (2023-2032)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2023-2032)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2023-2032)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2023-2032)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2023-2032)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Type (2023-2032)
10.3.2. Market Revenue Forecast by Form (2023-2032)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2023-2032)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2023-2032)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2023-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2023-2032)
10.4. LATAM
10.4.1. Market Revenue Forecast by Type (2023-2032)
10.4.2. Market Revenue Forecast by Form (2023-2032)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2023-2032)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2023-2032)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Type (2023-2032)
10.5.2. Market Revenue Forecast by Form (2023-2032)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2023-2032)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2023-2032)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2023-2032)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2023-2032)

Chapter 11. Company Profiles

11.1. Archer Daniels Midland Company
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Product Type
11.1.3. Revenue, Price, and Gross Margin (2023-2032)
11.1.4. Recent Developments and Strategies
11.2. General Mills, Inc.
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Product Type
11.2.3. Revenue, Price, and Gross Margin (2023-2032)
11.2.4. Recent Developments and Strategies
11.3. E. I. du Pont de Nemours and Company
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Product Type
11.3.3. Revenue, Price, and Gross Margin (2023-2032)
11.3.4. Recent Developments and Strategies
11.4. Aland (Jiangsu) Nutraceutical Co., Ltd.
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Product Type
11.4.3. Revenue, Price, and Gross Margin (2023-2032)
11.4.4. Recent Developments and Strategies
11.5. BASF SE
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Product Type
11.5.3. Revenue, Price, and Gross Margin (2023-2032)
11.5.4. Recent Developments and Strategies
11.6. Cargill, Incorporated
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Product Type
11.6.3. Revenue, Price, and Gross Margin (2023-2032)
11.6.4. Recent Developments and Strategies
11.7. Royal DSM N.V.
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Product Type
11.7.3. Revenue, Price, and Gross Margin (2023-2032)
11.7.4. Recent Developments and Strategies
11.8. Groupe Danone S.A.
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Product Type
11.8.3. Revenue, Price, and Gross Margin (2023-2032)
11.8.4. Recent Developments and Strategies
11.9. Nestle S.A.
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Product Type
11.9.3. Revenue, Price, and Gross Margin (2023-2032)
11.9.4. Recent Developments and Strategies
11.10. PepsiCo Inc.
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Product Type
11.10.3. Revenue, Price, and Gross Margin (2023-2032)
11.10.4. Recent Developments and Strategies

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms

Booklet
  • 発行日 :
    Aug-2024
  • 予想年 :
    2024年~2032年
  • 納期 :
    即日から翌営業日

ご要望に応じて日本語のレポートもご用意いたします。

ライセンスタイプを選択

シングルユーザーライセンス

699,165 円

マルチユーザーライセンス

854,535 円

法人ライセンス

994,368 円

お問い合わせ